Annual Report 2013

2

Table of contents

3 Foreword 4 2013 Highlights 6 Outstanding Performance Despite Major Challenges 12 2013 in Numbers 16 Health Services 17 Research 18 Education and Teaching | Training 19 Organizational Structure 20 Overview of Medical Facilities and Institutes 23 Legal notice

Frontispiece: Detail of the Charité Campus Clinic (CCK)

3

The year 2013 was an exceptionally challenging one for Charité – Universitätsmedizin Berlin The

year again proved successful in economic terms, despite major challenges posed by extensive

construction measures. None of this would have been possible without our 16,700 hard-working

and committed staff members. The board would like to take this opportunity to heartily thank all

of our dedicated employees.

It is particulary satisfying when such good performance is recognized by others, for instance in

“Focus” magazine’s national hospital ranking survey. As in 2012, the Charité was again the overall

winner in 2013, having received the distinction as Germany’s best hospital.

With a view to further improving medical care and offering our patients state-of-the-art hospital

rooms, the largest renovation project in the history of the merged Charité began in 2013, entailing

the refurbishment of the high-rise hospital structure that was built in 1982. The first step was to

build a substitute construction comprising 150 individual modular structures. This new Charité

Campus Clinic facility now temporarily houses 339 beds from the high-rise building. The move in

September was meticulously planned and ran smoothly. The involved staff members can be very

proud of this enormous achievement.

Construction work continues not only in Berlin Mitte, but also on the Virchow Hospital Campus

and Campus Benjamin Franklin. The Virchow Hospital Campus received a new diesel-powered

emergency generator, while at Campus Benjamin Franklin the old OP rooms were transformed

into ten new operating rooms with state-of-the art technology.

Cooperation with the Berlin Institute of Health (BIH) was a further major project started in June of

2013. The Charité and the Max Delbrück Center for Molecular Medicine in Berlin-Buch will combine

their research efforts at this new institute. The aim of this joint project is to ensure that patients

can more quickly benefit from medical research findings.

For fiscal year 2013, in the area of hospital operations the Charité achieved an annual result

amounting to 1.6 million euros for the third year in a row (not including the special effects

resulting from the dissolution of third party funding obligations). With only one third of all

university hospitals in Germany achieving a positive annual result, we are pleased with what

we were able to accomplish.

The profit and loss statement for 2013 includes a special effect resulting from accumulated

third party research funding totaling 34.7 million euros. These retained earnings will be re-

leased for research funding purposes in their full amount.

Foreword

Prof. Dr. Karl Max Einhäupl Prof. Dr. Annette Grüters-Kieslich Matthias Scheller Prof. Dr. Ulrich Frei Chairman of the Board Dean Hospital Director Medical Director

Moving in to the Charité Campus Clinic:First patient is greeted in the new ward

First modular patient room: Each 27-ton module delivered via heavy goods transport

Showcase project of the Charité and Vivantes:New headquarters for Labor Berlin on Campus Virchow-Klinikum

New intensive care unit:Medical apparatus in the background and sound-proofing

Master plan project for 19 million euros at Campus Benjamin Franklin:Modernizing of 10 operating rooms and OP unit

DSO honors the Charité:Award for commitment to the field of organ transplantation

New selection procedure for prospective students:Just 2 hours, time to answer 80 science questions

Modern hospital building in modular design:150 Modules for the Charité Campus Clinic

Comfortable hospital rooms at Charité Campus Clinic:339 Modern beds and media units for patients

Showcase project can save lives:Study demonstrates success of mobile stroke unit (STEMO)

New arrival at the Charité Campus Clinic:Baby Arvid is the first guest to arrive in the maternity ward

Charity for Charité:Berlin Children’s Choir singing in support of the Pediatric Clinics

6

Major construction measures startedFor the Charité, the year 2013 was characterized by con-

struction and remediation activities throughout our facili-

ties in Berlin Mitte. Preparations were initiated for the most

wide-ranging renovation project in the history of the Charité

merger: the comprehensive modernization of the high-rise

hospital building known as the Bettenhochhaus first built

in 1982. According to the master plan this structure will be

completely refurbished and receive a new facade; moreover,

a new state-of-the-art building on Philippstrasse will house

the Department of Emergency Medicine and Central OP and

Intensive Care areas.

The main concern of the responsible Charité planning team

composed of seven colleagues was to ensure safe and com-

fortable accommodations for our patients during the con-

struction phase. Together with the Board of Directors the

team of experts decided to transfer patient care services

from the high-rise building to the provisional Charité Campus

Clinic, a very high quality modular structure. The advantages

of this decision were obvious: patients would not be exposed

to annoying construction noise and the remediation mea-

sures could be carried out in a single construction phase.

The first module to house patient rooms was hoisted into

place in February of 2013. By mid-August, the four-storey

modular system composed of 150 modules was ready to ad-

mit patients. The building houses 9 wards with a total of 339

beds in state-of-the-art equipped and comfortably appointed

patient rooms. The Charité Campus Clinic provides a fore-

taste of the high-rise building after renovation: brightly lit

and pleasantly appointed rooms, large wheelchair-accessible

patient bathrooms and internet-enabled multimedia devices

at the patient’s bedside.

Moving the wards from the 24-floor high-rise building to the

new facility was an organizational tour de force: 3,000 rooms

occupying 25,000 square meters of floor space, including

19 wards, laboratories, offices and technological facilities,

had to be cleared. The overriding priority for all these ac-

tivities was to ensure seamless patient care. The planning

team elected to carry out the move in several stages. It took

18 long months to compile and adjust the overall plan and to

incorporate the various needs of physicians, nursing staff and

caregivers as future users of the Charité Campus Clinic. Six

weeks and 45 truck loads later, just 50 staff members had

already succeeded in moving everything from the high-rise

building to the new facility. Thanks to excellent preparatory

work the entire move was carried out within the allotted

time and budget.

The planning team paid particular attention to how the

patients were to be transferred. The pedestrian bridge connect-

ing the high-rise building and the Charité Campus Clinic

seemed the best option to transport the patients from one

building to the other. All the patients were pleasantly sur-

prised to find such bright comfortable rooms and new beds.

The Charité Campus Clinic has become very popular and

occupancy rates are nearly 100 percent.

General contractors for high-rise renovationConstruction work began on the high-rise building in Ja-

nuary of 2014. A consortium comprising Ed. Züblin AG and

VAMED Management and Service GmbH Deutschland was

appointed as the general contractor. Over the next three

years a total of 202.5 million euros will be spent on the

renovation of the high-rise building located on the Charité

Campus in Berlin Mitte and on upgrading to state-of-the-art

medical technology.

Outstanding Performance Despite Major Challenges

7

Construction work on all campusesThe Charité is rejuvenating all its campuses. Numerous pro-

jects are being implemented in the context of the master

plan and are contributing significantly to the enhancement

of existing campus structures. Technical improvements in-

clude a new diesel-powered emergency generator for the

Virchow Hospital Campus. The generator costing 5.86 million

euros starts automatically in case of sudden power outages,

which in turn ensures the proper functioning of essential and

life-sustaining machinery. A high-voltage switching station

and two diesel-powered emergency generators guarantee

adequate power supply during outages. The unit became

operational in early 2014 and is the first step in the ongoing

restructuring of Campus power supply facilities.

In the context of the master plan, ten new operating rooms

are currently being set up on the Campus Benjamin Franklin.

The old operating rooms built during the 1960s will be re-

placed and their spatial structures and building technology

systems updated in order to bring them in line with con-

temporary requirements. This will result in a more spacious

surgery section for example. The installation of the most

up-to-date medical information technology will also improve

access to cutting-edge high-tech environments. Construction

and remediation measures were started in the fall of 2013

and should be completed by early 2016 within the framework

of two separate construction phases involving five OP rooms

each. The related cost is estimated at 19 million euros. To

ensure that surgeries can continue at the same pace during

the renovation phase, the remaining operating rooms in the

central surgery section and other in-house facilities are to

be used more intensely.

Board members reconfirmedIn August 2013, the Charité supervisory board reconfirmed

Prof. Dr. Karl Max Einhäupl as its Chairperson by extend-

ing his term of office for five years. Before that, Dean

Prof. Dr. Annette Grüters-Kieslich was also reelected and

Matthias Scheller appointed to another five-year term as

the Hospital Director. In December, Prof. Dr. Ulrich Frei was

reelected to the post of Medical Director by the professors

of the clinical centers and confirmed by the supervisory

board. In this way the supervisory board expressed its

confidence in all the members of the Charité executive

board again in 2013.

Successfully defending our top rankingIn “Focus” magazine’s hospital ranking survey for 2013,

the Charité was able to defend its top position from the

previous year: the Charité is again by far the overall winner.

In the majority of the surveyed specialist fields Charité

again achieved the leading position. The list of hospitals

assessed in “Focus” is the result of the most comprehensive

nationwide quality comparison of more than 2,000 hospi-

tals in Germany. Assessment variables included success

rates, patient safety, clinical quality management measures,

technical facilities, professional staff qualifications and,

above all, recommendations by more than 22,000 medical

specialists.

Outstanding Performance Despite Major Challenges

417

100

Locations

Charité Centers

Hospitals and Institutesalmost

8

Intensive care unit of the future In October 2103, Charité presented the intensive care unit of

the future at the Virchow Hospital Campus. Unlike customary

intensive care units with their technical apparatus, ‘bee-

ping’ sounds and alarms, a modern unit features a pleasant

patient-friendly atmosphere with soft light and dark wood in

the foreground. Two rooms with four beds each have been

designed in such a way that patients and their loved ones can

benefit from maximum privacy: medical machinery is kept

in the background and alarm noises are muffled. Artificial

skies arch over patient beds with clouds passing over during

the day and stars twinkling at night. This helps to reduce the

risk of dangerous postoperative delirium. The pilot project

“Parametric Interior Design” was carried out by the Charité

in cooperation with architects from GRAFT – Gesellschaft von

Architekten mbH, ART+COM AG and Charité CFM Facility Man-

agement GmbH. Over a period of 18 months, experts in the

fields of intensive care, psychology, sleep research, architec-

ture and media design will explore how room design can

influence the patient healing process.

Robotic operating room inauguratedA next-generation operating room was inaugurated in De-

cember 2013 at the Virchow Hospital Campus. Cutting-edge,

robotics-assisted surgery utilizes the most modern devices

and technologies in support of innovative surgical methods.

This allows physicians to reduce surgery time and thereby

reduce anesthesia times. The OP team also benefits from

the simplified handling of medical apparatus. Touch panels,

high definition displays and monitors over the operating

table transform the operating theater into a cutting-edge

treatment room. The operation room can be used for various

disciplines and is the result of close cooperation between

Charité‘s medical and technical personnel and its technology

partner TRUMPF Medizin Systeme GmbH + Co. KG.

Showpiece project: Mobile Stroke UnitWhen a stroke occurs, every minute counts. This is because

no other tissue suffers irreversible damage from interrupted

blood supply as rapidly as brain tissue. The Mobile Stroke

Unit (STEMO) is a specially designed rescue vehicle equipped

with a computer tomograph scanner and a mini-laboratory,

specially trained rescue personnel and a neurologist with

emergency response qualifications. A full-scale study carried

out by the Charité examining 7,000 patients over a period

of 21 months has now revealed that STEMO is significantly

more effective in the treatment of stroke patients and also

significantly reduces response times. STEMO was shown to

reduce the time between the initial emergency call and the

initiation of treatment, in addition to a marked increase

in the frequency of lysis. With the aid of medications, lysis

therapy serves to dissolve blood clots that block brain arte-

ries. STEMO also symbolizes the first-class cooperation that

exists between the Charité, the Berlin Fire Department and

two technology firms in the state of Brandenburg that were

instrumental in jointly developing the emergency vehicle.

Charity for CharitéJust prior to Christmas 2013, the Charité Pediatric Clinics

organized a benefit gala entitled “Charity for Charité”.

“Keeping our children healthy” was the main theme that at-

tracted more than 200 guests and prominent citizens to the

gala to show their solidarity with the needs of the Pediatric

Clinics. Donations amounting to more than 100,000 euros

were received in support of urgently needed health servi-

ces for children and adolescents. The Charity gala focused

on five specific services offered by the Pediatric Clinics in

the fields of prevention, treatment and aftercare. The pro-

ceeds from that evening are to be placed at the disposal of

the following Charité projects: ongoing development of an

Interdisciplinary Ward for Children with Serious Rare Disea-

9

ses and the Safe House for Children, as well as continuing

support for the Berlin Trauma Outpatient Service for Children

and Adolescents, the Aftercare Program for Families with

Seriously Ill Children, and the prevention project entitled

“Babylotse Plus” for infants and their parents. In the name of

all the Pediatric Clinics at the Charité, Dean Prof. Dr. Annette

Grüters-Kieslich thanked the many ambassadors for impro-

ved pediatric health, the artists, the partners and sponsors,

as well as the volunteers that made such an event possible.

DSO honors the CharitéIn its role as an independent organization, the German Or-

gan Transplantation Foundation (DSO) honored the Charité

for its ongoing commitment in the area of organ transplants.

At a celebratory event, Mario Czaja, Berlin’s Senator for

Health and Social Affairs, and Dr. Detlef Bösebeck, Man-

aging Physician of the DSO, presented the Charité with a

certificate and a commemorative sculpture. Approximately

4,000 people received a new organ in Germany last year

and were given a second chance at life. More than 11,000

people in Germany are currently waiting for a donor organ,

yet the number of donations is at an all-time low. The rea-

sons for receiving this award included the dedicated support

provided by hospital management to the transplantation

representative, continuing education of hospital personnel,

elaboration of guidelines for emergency organ donation,

and implementation of the organ donation process as a

normal medical care obligation.

Central operational facility for Labor BerlinLabor Berlin, the exceedingly successful joint project

between Charité and Vivantes, moved into its new head-

quarters in April of 2013. This facility offers space for

9 departments that were previously distributed across

13 locations to work together under one roof. Europe’s lar-

gest hospital laboratory can now perform its diagnostic

tasks at a central site in a concentrated and unified manner.

In the future, this facility will provide high performance

diagnostic services for more than 10,000 hospital beds in

and around Berlin, and will continue to provide high-quality,

on-site emergency care at all hospital locations under the

aegis of Charité and Vivantes.

Exemplary cooperation with Vivantes In 2013, the Charité and Vivantes initiated their own dedi-

cated network for the treatment of ovarian cancer. Their

activities include online tumor conferences on how to best

deal with the disease which is contracted by approximately

8,000 women in Germany each year. The conference takes

place over two weeks, during which physicians discuss the

clinical pictures of the patients with a committee of ex-

perts and together jointly develop therapy recommenda-

tions. The aim of this cooperative effort is to significantly

improve the treatment of patients with ovarian cancer in

the Berlin and Brandenburg region, and beyond.

10

Berlin Institute of Health openedThe Berlin Institute of Health (BIH) was inaugurated in June

2013 at an official ceremony. Its board members include Prof.

Dr. Ernst Theodor Rietschel (chairperson), Prof. Dr. Walter

Rosenthal, Prof. Dr. Karl Max Einhäupl and Prof. Dr. Annette

Grüters-Kieslich. The BIH combines the research capabili-

ties of the Helmholtz Association’s Max-Delbrück Center

for Molecular Medicine Berlin-Buch (MDC) and the Charité,

one of the largest university hospitals in Europe. The aim of

the institute is to better translate research findings into real

hospital settings. As such, Germany now has its first ever

holistic and medical systems-based research facility. The

federal and state governments and the Helmholtz Associa-

tion are providing funds in the amount of approximately 300

million euros to the MDC and Charité to further develop the

BIH over the next 5 years. The benefactress of the Charité

Foundation, Johanna Quandt, is also supporting the BIH

project with 40 million euros.

Science and Social Responsibility: GeDenkOrt.CharitéIn the context of Berlin’s theme year 2013 “Diversity De-

stroyed”, the Charité has erected two commemorative co-

lumns to honor its staff, physicians and research assistants

who were expelled or died during the National Socialist

period. One of the columns bears inscriptions of the names of

the 180 Charité members identified to date along with rele-

vant biographical information. Exclusion and expulsion have

become important topics of discussion at the Charité. In Ger-

many, and in Berlin in particular, numerous monuments are

dedicated to Germany‘s past. Until now, however, the Charité

has lacked a visible, centrally located place of remembrance,

and despite a few steps in this direction, no comprehensive

historical-scientific analysis of the NS period has yet been

undertaken. In this context, “GeDenkOrt.Charité” represents

a highly significant and high-priority project which aims to

close long-standing gaps in our culture of remembrance and

expose historical realities that in turn influence the contem-

porary and future identity of such an historic institution.

As an internationally renowned university hospital where

physicians and scientists research, heal and teach at the

highest levels and where students are trained and subse-

quently disseminate learned knowledge to the outside world,

the Charité now strives to set and to adhere significantly

higher standards.

World Health SummitIn October of 2013, health policy decision makers from 80

countries gathered once more in Berlin on the occasion of the

World Health Summit (WHS). Under the auspices of the Ger-

man Chancellor Angela Merkel, the French President Fran-

çois Hollande and the President of the European Commis-

sion, José Manuel Barroso, the gathering discussed possible

solutions in terms of a global approach to healthcare. The

Charité has been the organizer of the WHS since 2009 and

participated in many important events again this year, and

in doing so provided key input on issues such as prevention,

education and academic responsibility. The mission of the

WHS is to improve global health. To this end the spheres of

science, industry, politics and civil society need to cooperate

more closely and take greater joint responsibility for this

issue.

HAM-NatA first for the Charité: with a pencil in one hand and an ID in

the other, approximately 700 prospective students submitted

applications to take the Hamburg Natural Science Test (HAM-

Nat) for the first time in September 2013 for enrolment in the

winter term 2013 / 2014. They were all vying for the highly

coveted admission to medical or dental studies at the Charité.

11

The HAM-Nat is a scholastic aptitude test that has replaced

the customary personal interviews with prospective stu-

dents. The test examines an applicant’s skills in subject areas

related to the fields of mathematics and the natural sciences.

During a two-hour examination, the candidates must answer

around 80 questions from the fields of mathematics, physics,

biology and chemistry. The test was conceived at the Univer-

sity of Hamburg and further elaborated in conjunction with

the Charité and the University of Magdeburg.

Charité and the Sorbonne cooperateThe Centre Virchow-Villermé was established in April 2013

on the occasion of ceremonies commemorating the 50th

anniversary of the Élysée Treaty. The aim of this joint center

administered by the Charité and the Sorbonne Paris Cité is

to promote innovative interdisciplinary research in the area

of public health and to create innovative course materials.

Two professorships have been granted to date. Sanofi-Aventis

Deutschland GmbH is providing funding in the amount of one

million euros for the first five years of each professorship.

Einstein Professorship at the CharitéWith the appointment of Prof. Dr. Angelika Eggert, the Cha-

rité has now earned its second Einstein Professorship. Prof.

Dr. Eggert is taking over the Pediatric Clinic specializing in

oncology and hematology. A renowned specialist in pediatric

cancer, she is considered one of Germany‘s leading oncolo-

gists and is an excellent and highly active scientist. One of

her goals is to launch a dedicated research network. The

Charité has again succeeded in appointing a woman to an

important chair, thereby maintaining its leading position in

Germany in terms of delegating academic chairs to talented

female scientists.

HU and Charité research togetherIn the spring of 2013, the Charité, the Humboldt University

of Berlin (HU) and the Max Delbrück Center for Molecular

Medicine Berlin-Buch (MDC) established the Integrative

Research Institute (IRI) for the Life Sciences. The aim was to

further develop the Humboldt’s north campus area into an

important science park in the heart of Berlin, and together

to promote basic research activities in systems biology and

theoretical biology, the neurosciences, as well as infec-

tion biology and immunology. IRI scientists conduct joint

research into life itself, from the molecular to the more

complex levels of organic life with a view to strengthening

the focus on prevention, diagnostics and therapy in daily

clinical practice.

Clinical Trial Management Unit (CTMU)The Clinical Trial Management Unit (CMTU) provides im-

portant support for excellent clinical research at the Cha-

rité. It supports the coordination and conduct of industry-

sponsored clinical studies at the Charité. The aim of this

new facility is to ensure adherence to high quality standards

in patient-oriented clinical research projects, to optimize

infrastructures, and to offer general support for research

activities at the Charité. This cooperation with industry in

the context of clinical studies makes it possible for Charité

clinics to offer the most cutting-edge medicinal therapeutic

strategies emanating from pharmaceutical development

pipelines. In this way patients will be able to gain access to

the most innovative therapies.

12

ProfitabilityCharité – Universitätsmedizin Berlin comprises more than

100 medical facilities and institutes distributed across four

separate locations: the Benjamin Franklin Campus, Berlin

Buch Campus, Charité Mitte Campus and Virchow Hospital

Campus. The Charité Group employs a total of approximately

16,700 staff members in the areas of health care, research,

teaching, services, administration and external funding. This

makes the Charité one of the largest employers in the Ger-

man capital.

With an overall turnover exceeding 1.4 billion euros and more

than 136,000 inpatient and 637,000 outpatient cases, the

Charité achieved revenues amounting to 816.2 million euros

for the 2013 reporting period. This breaks down to 717.2

million euros of revenues from inpatient care, 58.6 million

euros from outpatient care services, and charges for elec-

tive procedures and fees for the use of medical facilities by

private doctors in the overall amount of 40.4 million euros.

The Charité received grants and allocations from the State of

Berlin in the amount of 197.9 million euros. Other operating

income amounted to 338.7 million euros.

Staffing costs were the largest single expenditure item.

This amounted to 745.7 million euros, corresponding to an

increase of 4.3 million euros when compared with the pre-

vious year. The cost of materials rose by 22.8 million euros

to a total of 393.1 million euros. Other operating expenses

amounted to 211.3 million euros, including 71.3 million euros

for maintenance needs.

Net earnings amounted to 36.3 million euros overall for the

reporting period. Even without the dampening special effect

in the amount of 34.7 million euros due to the dissolution

of external funding obligations — with its net earnings of 1.6

million euros — the Charité has achieved a positive result

for the third year in a row, and has again exceeded its own

ambitious business plan goals. The successful course of eco-

nomic consolidation continued in 2013 as well, despite a

further reduction of 84 beds. This improvement in the

Charité’s economic underpinning was made possible by the

hard work of our staff in furthering the Charité’s economic

reform process, which in turn facilitated the implementati-

on of an extensive portfolio of improvements in structural

efficiency. We were able to balance and even overcompensate

for these losses, despite a further increase in expenditures

due to tariff agreements and inflationary effects, as well as

additional costs for construction measures.

InvestmentsThe Charité invested a total of 72.9 million euros in both

tangible and intangible assets over the course of the fiscal

year. A major portion of these investments was financed by

the State of Berlin in the form of subsidies for health services

and research and teaching; the regular investment subsidies

of the State of Berlin amounted to 33.7 million euros.

2013 in Numbers

13

PROFIT AND LOSS STATEMENT

2012 2013 in T€ in T€

Sales revenue* 801,361 816,190

Changes in inventory 1,072 -199

Public grants and subsidies 191,743 197,903

Other operating income 345,758 338,743

1.339,934 1.352,638

Personnel costs 741,427 745,729

Cost of materials 370,350 393,127

Interim result 228,156 213,781

Result from subsidized items related to hospital operations 55,460 133,370

Depreciation of intangible assets and tangible assets 75,251 84,935

Other operating expenditures 184,450 211,266

Interim result 23,915 50,950

Financial result -12,193 -13,277

Result from ordinary business activities 11,722 37,673

Extraordinary expenses 2,110 3,959

Tax income / expense -4,389 2,588

Net income the year 5,223 36,303

5,223 1,593

* Sales revenue is defined as proceeds from hospital servi-ces, optional medical services, outpatient services, and reve-nues from elective procedures conducted by physicians.

2013 in Numbers

Net income the year not including the special effect of the dissolution of third party funding obligations

36.3

8.2 2008 2009 2010 5.2 2011 2012 2013

-19.2 -17.8

-56.6

14

PROFIT AND LOSS SUMMARY

31 Dec 2012 31 Dec 2013 ASSETS in T€ in T€

A. Fixed assets

I. Intangible fixed assets 1,665 1,683

II. Tangible assets 1.170,953 1.129,961

III. Financial assets 3,642 3,642

1.176,259 1.135,286

B. Current assets

I. Inventories 48,504 50,475

II. Receivables and other assets 232,760 252,305

III. Cash on hand, deposits in land central bank, bank deposits 90,951 86,406

372,215 389,185

C. Deferred income 3,805 3,862

D. Deficit not covered by equity 9,871 0

1.562,151 1.528,333

LIABILITIES

A. Capital resources

1. Capital 164,346 164,346

2. Revenue reserves 1,800 1,800

3. Loss carried forward -181,240 -176,016

4. Net income the year 5,223 36,303

5. Loss not covered by equity 9,871 0

0 26,432

B. Special items to finance fixed assets 967,205 930,390

C. Provisions 314,773 326,668

D. Liabilities 275,498 238,002

E. Deferred income 4,672 6,841

1.562,151 1.528,333

230 Professors4.075 Nursing staff13.100 Charité Staff members of those

15

CHANGES IN STAFFING LEVELS

ø FT ø FT Development 2012 2013 of fte

Active full-time staff (FT) total 9,719.9 9,609.2 6.2

of those:

Medical services 2,080.9 2,075.7 30.3

Nursing services 2,474.7 2,437.7 -17.5

Medical-technical services 2,522.8 2,465.7 -43.7

Functional services 1,127.9 1,125.2 -55.1

Operating and supply services 366.8 369.1 -14.2

Technical services 199.9 203.6 -16.0

Administrative services 815.8 778.4 -5.3

Special services 78.0 96.4 -0.2

Staff training services 53.1 57.4 -0.7

Inactive full-time staff 1,228.3 1,230.4 46.6

Active full-time staff (externally funded) 1,617.3 1,548.4 -76.4

Full-time staff total 12,565.5 12,388.1 -14.5

Students 297.3 302.2 -5.4

Midwife trainees 40.9 38.7 15.9

Trainees 90.9 91.6 --1.9

Personnel

729 Administrative staff3.710 Scientists and physicians

32%

68%

16

Health services

2012 2013 total total

Number of officially authorized beds 3,095 3,011

Beds available 3,095 3,011

Utilization rate 86.0 83.4 (average number of available beds in %)

Average occupancy in days 6.39 6.05

Occupancy days 948,571 881,981

Inpatient cases 140,706 136,440

Outpatient cases 615,694 637,171

0

50

100

150

200

250

Memory

Adult autism

Polyposis syndrome

Amyotrophic lateral sclerosis (ALS)

Anaplastology Psoriasis

Muscle disease

Short bowel syndrome

200

150

100

50

0

Number of cases and casemix points, in thousands

Inpa

tien

t ca

ses

case

mix

po

ints

Clinic Ranking(Focus 23|2013)

SpeCial CONSUlTiNG HOURS

number 1Charité

Age-related macular degenerationSclerodermia

Movement disorders

Early onset arthritis

Transplantation Surgery

Immunodeficiency

2005 2006 2007 2008 2009 2010 2011 2012 2013

159 163174

182187

117127 130 130

133

193198

204

136 139 140

195

136

Ataxia

Consultation for rare diseases

Consultation for rare diseases Hyperhidrosis

17

Research

Trends in state grants and external funding

million

euros

300

250

200

150

100

50

0

Collaborative Research Centers155Excellence projects3Excellence projects

with host function

3 Federal Research Ministry Competency Networks

Collaborative Research Centers with host function

84Clinical Research Groups

7DFG Research Groups4DFG Graduate Schools

38.75 million euros German Research Foundation (DFG)

33.42 million euros Business/industry and donations

36.2 million euros Federal Ministry

14.5 million euros European Union

13.96 million euros Foundations

8.45 million euros Other2.63 million euros Land of Berlin

148 million euros

procured external

funding

Focus of research activities

• Immunological science

• Cardiovascular research

and metabolism

• Neuroscience

• Oncology

• Regenerative therapies

• Rare diseases and genetics

0

50

100

150

200

250

300

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

255 258 251245 240

229216

203190

177184 189

8897 98

108101 105

116130 127

151 153 148154

195

stat

e gr

ants

exte

rnal

fun

ding

3 German Centersfor Health Research

18

* without Master

EDUCATION AND TEACHING

December December 2012 2013

Students, total 6,974 6,953

Number of degree courses 19 17

First-year students, total 1,377 1,389

of whom:

Medicine 696 697

Dentistry 99 102

Health science 61 66

Other 521 524

Graduates, total * 776 771

of whom:

Medicine 634 607

Dentistry 96 84

Health science 46 80

OCCUPATIONAL TRAINING Occupational training at the Health Academy

620 traineeships in 8 different healthcare professions Midwifery Healthcare and nursing Healthcare and pediatric nursing Surgical-technical assistant Nutrition assistant Logopedics Physiotherapy Autopsy and preparation assistants

Further qualified occupatients

Medical assistantAnimal technicianAdministrative assistantDental assistantBiology lab assistantOffice assistantInformation systems assistant

Consumer Health Care

Public Health

Standard Medical Studies

Cerebrovascular MedicineDentistry

Health and Society:International Gender Studies Berlin

Medical Neurosciences – International Graduate Program

Molecular Medicine

Reformed Medical Curriculum

UNIVERSITY CURRICULUMEpidemiology Applied Epidemiology

BA in Health Science

Model Medicinal Studies

19

CC1 CC2 CC3 CC4 CC5 CC6 CC7 CC8 CC9

CC10 CC11 CC12 CC13 CC14 CC15 CC16 CC17

EXECUTIVE BOARDChairman of the Executive Board

Prof. Dr. Karl Max Einhäupl

Hospital DirectorMatthias Scheller

Medical DirectorProf. Dr. Ulrich Frei

DeanProf. Dr. Annette Grüters-Kieslich

Executive Secretary of the BoardDr. Jan Steffen Jürgensen

Clinical Center ManagementMatthias Scheller (Hospital Director)Prof. Dr. Ulrich Frei (Medical Director)

Evelyn Möhlenkamp (Nursing Director)Dr. Helmar Wauer (Hospital Business Director)

Faculty BoardProf. Dr. Annette Grüters-Kieslich (Dean)

Prof. Dr. Christian Hagemeier (Vice Dean for Research)

Prof. Dr. Claudia Spies (Vice Dean for Education)

Dr. Gerrit Fleige (Faculty Business Director)

Research

Marc Philipp

Study Affairs

Burkhard Danz

Central Academic and International

Academic AffairsDr. Mathias John

Corporate Controlling

Roland Kurney

Strategic Corporate

Development

N. N.

Staff

Christof Schmitt

Corporate Communications

Uwe Dolderer

IT

Helmut Greger

Legal Services

Christof Schmitt

Technologyand Operations

Toralf Giebe

Academy

Dr. Marianne RabeCarsta Prütz

Finance andPurchasing

Dr. Alexander Hewer

Buildings and Grounds Management

Christian Kilz

Pharmacy

Dr. Susan Bischoff

Office for Negotiations with Health Insurance

CompaniesCarsta Prütz

CHARITÉCENTERS

BUSINESS DIVISIONS

SPIN-OFFS AND HOLDINGSZTB Zentrum für Transfusionsmedizin und Zelltherapie Berlin gGmbH

Labor Berlin – Charité Vivantes Services GmbH

Labor Berlin – Charité Vivantes GmbH

Charité CFM Facility Management GmbH

CRO Charité Research Organisation GmbH

Charité Healthcare Services GmbH

Charité Physiotherapie- und Präventionszentrum GmbH

Ambulantes Gesundheitszentrum der Charité GmbH

Medizinisches Versorgungszentrum der Charité Mitte GmbH

Medical Faculty SenateChairman: Prof. Dr. Peter-André Alt and Prof. Dr. Jan-Hendrik Olbertz

Office: Dr. Gerda Fabert

Supervisory BoardChairwoman: Sandra Scheeres

Office of the Supervisory Board: Dr. Jan Steffen Jürgensen

Faculty CouncilChairwoman:

Prof. Dr. Annette Grüters-Kieslich

Office: Heike Stein

Organizational structures

CorporateGovernance

Marc Deffland

HospitalManagement

Marie le Claire

Last update: April 2014

20

Overview of the clinics and institutes

CC1 CharitéCenter for Health and Human Sciences Scientific Director Prof. Dr. Adelheid Kuhlmey +49 30 450 529 171 adelheid.kuhlmey@charite.de Managing Director Dr. Sabine Damm +49 30 450 529 181 sabine.damm@charite.de Director Berlin School of Public Health Prof. Dr. Jacqueline Müller-Nordhorn Institute of General Medicine Dr. Christoph Heintze (acting) Institute of Occupational Medicine Prof. Dr. Adelheid Kuhlmey (acting) Institute of the History of Medicine and Ethics in Medicine Prof. Dr. Volker Hess Institute of Healthcare Research TBA Institute of Health and Nursing Science Prof. Dr. Michael Ewers Institute of Medical Psychology Prof. Dr. Christine Heim Institute of Medical Sociology and Rehabilitation Science Prof. Dr. Adelheid Kuhlmey Institute of Sexology and Sexual Medicine Prof. Dr. Klaus Beier Institute of Social Medicine, Epidemiology and Health Economics Prof. Dr. Benno Brinkhaus

CC2 CharitéCenter for Basic Sciences (Year 1) Scientific Director Prof. Dr. Britta Eickholt +49 30 450 539 121 britta.eickholt@charite.de Managing Director Thomas Gazlig +49 30 450 528 181 thomas.gazlig@charite.de Director Specialty Network: Anatomy Institute of Integrative Neuroanatomy Prof. Dr. Imre Vida Institute of Vegetative Anatomy Prof. Dr. Sebastian Bachmann Institute of Cell Biology and Neurobiology Prof. Dr. Victor Tarabykin (acting) Specialty Network: Biochemistry and Molecular Biology Institute of Biochemistry Prof. Dr. Britta Eickholt Institute of Biochemistry and Molecular Biology Prof. Dr. Britta Eickholt | Prof. Dr. P.-M. Kloetzel Institute of Medical Physics and Biophysics Prof. Dr. Christian Spahn Institute of Molecular Biology and Bioinformatics Prof. Dr. Britta Eickholt (acting) Specialty Network: Physiology Institute of Neurophysiology Prof. Dr. Jörg Geiger Institute of Physiology Prof. Dr. Axel R. Pries Institute of Vegetative Physiology Prof. Dr. Pontus B. Persson

CC3 CharitéCenter for Dental, Oral and Maxillary Medicine Scientific Director Prof. Dr. Paul-Georg Jost-Brinkmann +49 30 450 562 522 paul-g.jost-brinkmann@charite.de Managing Director Manfred Datta +49 30 450 562 001 manfred.datta@charite.de Director Institute for Dental, Oral and Maxilary Medicine Prof. Dr. Paul-Georg Jost-Brinkmann

CC4 CharitéCenter for Therapy and Research Scientific Director Prof. Dr. Josef Köhrle +49 30 450 524 021 josef.koehrle@charite.de Managing Director Thomas Gazlig +49 30 450 528 181 thomas.gazlig@charite.de Director Specialty Network: Pharmacology and Toxicology Institute of Clinical Pharmacology and Toxicology Prof. Dr. Ulrich Kintscher (acting) Institute of Pharmacology Prof. Dr. Reinhold Kreutz Specialty Network: Biometry, Epidemiology and Medical Computer Science Institute of Medical Biometrics and Clinical Epidemiology Prof. Dr. Josef Köhrle (acting) Institute of Medical Informatics Prof. Dr. Thomas Tolxdorff Institute of Theoretical Biology Prof. Dr. Hans-Peter Herzel Institute of Experimental Endocrinology Prof. Dr. Josef Köhrle Associated: Gender in Medicine (GIM) Prof. Dr. Vera Regitz-Zagrosek

CC5 CharitéCenter for Diagnostic Laboratory and Preventive Medicine Medical Director Prof. Dr. Rudolf Tauber +49 30 8445 2555 rudolf.tauber@charite.de Managing Director Sina Wesoly +49 30 450 569 392 sina.wesoly@charite.de Managing MTA Sigrid Kersten +49 30 450 525 189 sigrid.kersten@charite.de Director Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry Prof. Dr. Rudolf Tauber Institute of Microbiology and Hygiene Prof. Dr. Ulf Göbel Institute of Virology | CBF Prof. Dr. Regine Heilbronn Institute of Virology | CCM Prof. Dr. Detlev Krüger Institute of Legal Medicine and Forensic Sciences Prof. Dr. Michael Tsokos Institute of Forensic Psychiatry Prof. Dr. Hans-Ludwig Kröber Institute of Pathology Prof. Dr. Manfred Dietel Institute of Hygiene and Environmental Medicine Prof. Dr. Petra Gastmeier

CC6 CharitéCenter for Diagnostic and Interventional Radiology and Nuclear Medicine Medical Director Prof. Dr. Bernd Hamm +49 30 450 527 082 bernd.hamm@charite.de Managing Director Arne Weber +49 30 450 527 091 arne.weber@charite.de Managing MTRA Susanne Ortmann +49 30 450 557 071 susanne.ortmann@charite.de Director Institute of Radiology (including Pediatric Radiology and Neuroradiology) Prof. Dr. Bernd Hamm Department of Nuclear Medicine Prof. Dr. Winfried Brenner Institute of Neuroradiology Prof. Dr. Bernd Hamm (acting)

21

CC7 CharitéCenter for Anesthesiology, Operating-Room Management a. Intensive Care Medicine Medical Director Prof. Dr. Claudia Spies +49 30 450 531 012 claudia.spies@charite.de Managing Director Dr. Matthes Seeling +49 30 450 651 121 matthes.seeling@charite.de Nursing Director Evelyn Starkiewicz +49 30 450 577 048 evelyn.starkiewicz@charite.de Director Department of Anesthesiology and Operative Intensive Care Medicine | CCM / CVK Prof. Dr. Claudia Spies Department of Anesthesiology and Operative Intensive Care Medicine | CBF Prof. Dr. Christoph Stein Operating Room Management (with OP and Anesthesia Functional Service) Prof. Dr. Claudia Spies/Prof. Dr. Christoph Stein

CC8 CharitéCenter for Surgery Medical Director Prof. Dr. Peter Neuhaus +49 30 450 552 001 peter.neuhaus@charite.de Managing Director Axel Köhler +49 30 450 522 001 axel.koehler@charite.de Nursing Director Annett Leifert +49 30 450 552 524 annett.leifert@charite.de Director Department of General, Visceral, Vascular and Thoracic Surgery | CCM Dr. Oliver Haase (acting) Department of General, Visceral and Transplantation Surgery | CVK Prof. Dr. Peter Neuhaus Department of General, Vascular and Thoracic Surgery | CBF Prof. Dr. Martin E. Kreis Department of Urology Prof. Dr. Kurt Miller

CC9 CharitéCenter for Traumatology and Reconstructive Surgery Medical Director Prof. Dr. Norbert Haas +49 30 450 552 012 norbert.haas@charite.de Managing Director Dipl.-Kfm. Gerald Linczak +49 30 450 552 728 gerald.linczak@charite.de Nursing Director Stefanie Bieberstein +49 30 450 577 051 stefanie.bieberstein@charite.de Director Department of Traumatology and Reconstructive Surgery Prof. Dr. Norbert Haas inculding Department of Orthopedic Surgery | CVK / CCM Julius Wolff Institut of Biomechanics and Musculoskeletal Regeneration Prof. Dr.-Ing. Georg Duda Department of Traumatology and Reconstructive Surgery | CBF Prof. Dr. Wolfgang Ertel Department of Oral and Maxillofacial Surgery Prof. Dr. Dr. Bodo Hoffmeister

CC10 Charité Comprehensive Cancer Center Medical Director Prof. Dr. Ulrich Keilholz (acting) +49 30 450 513 501 ulrich.keilholz@charite.de Managing Director Dr. Regina Jünger +49 30 450 540 011 regina.juenger@charite.de Director Charité Comprehensive Cancer Center Prof. Dr. Ulrich Keilholz (acting)

CC11 CharitéCenter for Cardiovascular Diseases Medical Director Prof. Dr. Gert Baumann +49 30 450 513 072 gert.baumann@charite.de Managing Director Dipl.-Kfm. Gerald Linczak +49 30 450 552 728 gerald.linczak@charite.de Nursing Director Stefanie Bieberstein +49 30 450 577 051 stefanie.bieberstein@charite.de Director Department of Cardiology and Pulmonology (including Angiology) | CBF Prof. Dr. Heinz-Peter Schultheiß Department of Cardiovascular Surgery Prof. Dr. Wolfgang Konertz Medical Department, Division of Cardiology and Angiology | CCM Prof. Dr. Gert Baumann Medical Department, Division of Cardiology | CVK Prof. Dr. Wilhelm Haverkamp (acting)

CC12 CharitéCenter for Internal Medicine and Dermatology Medical Director Prof. Dr. Gerd-Rüdiger Burmester +49 30 450 513 061 gerd.burmester@charite.de Managing Director Juliane Maryam Salehin +49 30 450 552 201 juliane.salehin@charite.de Nursing Director Barbara Jung +49 30 450 677 026 barbara.jung@charite.de Director Medical Department, Division of Rheumatology and Clinical Immunology | CCM Prof. Dr. Gerd-Rüdiger Burmester (including Physical Medicine) | CBF / CCM Medical Department, Division of Infectiology and Pneumonology |CCM / CVK Prof. Dr. Norbert Suttorp (including Pneumonological Oncology) Medical Outpatient | CCM Prof. Dr. Jürgen Scholze Department of Dermatology, Venerology and Allergology Prof. Dr. Torsten Zuberbier (acting) Institute of Medical Immunology Prof. Dr. Hans-Dieter Volk Medical Department, Division of Psychosomatic Medicine Prof. Dr. Matthias Rose

CC13 CharitéCenter for Internal Medicine with Gastroenterology and Nephrology Medical Director Prof. Dr. Bertram Wiedenmann +49 30 450 553 022 bertram.wiedenmann@charite.de Managing Director Dr. Werner Wyrwich +49 30 450 513 181 werner.wyrwich@charite.de Nursing Director Dagmar Hildebrand +49 30 450 577 368 dagmar.hildebrand@charite.de Director Specialty Network: Nephrology Medical Department, Division of Nephrology and Internal Intensive Care Medicine | CVK Prof. Dr. R. Schindler | Prof. Dr. A. Jörres (acting) Medical Department, Division of Nephrology | CCM Prof. Dr. Hans-Hellmut Neumayer Department of Nephrology | CBF Prof. Dr. Walter Zidek

22

Specialty Network: Gastroenterology, Endocrinology and Metabolic Diseases Medical Department, Division of Hepatology and Gastroenterology | CVK / CBF Prof. Dr. Bertram Wiedenmann (including Metabolic Diseases) Department of Gastroenterology, Infectiology and Rheumatology | CBF Prof. Dr. Britta Siegmund (acting) (including Nutrition Medicine) Department of Endocrinology and Metabolic Diseases Prof. Dr. Joachim Spranger Institute of Clinical Physiology TBA Divison of Lipid Metabolism Prof. Dr. Elisabeth Steinhagen-Thiessen Emergency Department | CBF Prof. Dr. Rajan Somasundaram Emergency Departments | CVK / CCM Prof. Dr. Martin Möckel

CC14 CharitéCenter for Tumor Medicine Medical Director Prof. Dr. Bernd Dörken +49 30 450 553 111 bernd.doerken@charite.de Managing Director Dr. Felix Mehrhof +49 30 450 513 274 felix.mehrhof@charite.de Nursing Director Judith Heepe +49 30 450 577 098 judith.heepe@charite.de Director Medical Department, Division of Hematology, Oncology | CBF Prof. Dr. Antonio Pezzutto Medical Department, Division of Hematology, Oncology and Tumor Immunology | CVK Prof. Dr. Bernd Dörken Medical Department, Division of Oncology and Hematology | CCM Prof. Dr. Hanno Riess Department of Radiation Oncology and Radiotherapy | CCM / CVK Prof. Dr. Volker Budach Department of Radiation Oncology and Radiotherapy | CBF Dr. Lutz Moser Institute of Immunology Prof. Dr. Thomas Blankenstein Institute of Transfusion Medicine Prof. Dr. Abdulgabar Salama

CC15 CharitéCenter for Neurology, Neurosurgery and Psychiatry Medical Director Prof. Dr. Matthias Endres +49 30 450 560 101 matthias.endres@charite.de Managing Director PD Dr. Uwe Reuter +49 30 450 560 274 uwe.reuter@charite.de Nursing Director Sinah Bischoff-Everding +49 30 450 677 035 sinah.bischoff@charite.de Director Department of Neurology with Experimental Neurology Prof. Dr. Matthias Endres Department of Psychiatry and Psychotherapy | CBF Prof. Dr. Isabella Heuser-Collier Department of Psychiatry and Psychotherapy | CCM Prof. Dr. Andreas Heinz Department of Neurosurgery with Pediatric Neurosurgery Prof. Dr. Peter Vajkoczy Institute of Neuropathology Prof. Dr. Frank Heppner

CC16 CharitéCenter for Audiology / Phoniatrics, Ophthalmology and Otolaryngology Medical Director Prof. Dr. Manfred Gross +49 30 450 555 401 manfred.gross@charite.de Managing Director Christoph Wigger +49 30 450 555 161 christoph.wigger@charite.de Nursing Director Diane Jetschmann +49 30 450 577 118 diane.jetschmann@charite.de Director Department of Ophthalmology Prof. Dr. Antonia Joussen Department of Audiology and Phoniatrics Prof. Dr. Manfred Gross Department of Otolaryngology Site Management CVK / CCM Prof. Dr. Heidi Olze Site Management CBF PD Dr. Minoo Lenarz

CC17 CharitéCenter for Gynecology, Perinatal, Pediatric and Adolescent Medicine with Perinatal Center and Human Genetics Medical Director Prof. Dr. Ulrike Lehmkuhl +49 30 450 566 202 ulrike.lehmkuhl@charite.de Managing Med. Director PD Dr. Uwe Reuter +49 30 450 566 321 uwe.reuter@charite.de Managing Director Juliane Kaufmann +49 30 450 566 341 juliane.kaufmann@charite.de Nursing Director Judith Heepe +49 30 450 577 098 judith.heepe@charite.de Sinah Bischoff-Everding +49 30 450 677 035 sinah.bischoff@charite.de Director Specialty Network: Perinatal Medicine Department of Obstetrics Prof. Dr. Wolfgang Henrich Department of Neonatology Prof. Dr. Christoph Bührer Further Facilities Department of Gynecology | CVK / CBF Prof. Dr. Jalid Sehouli (CBF acting) Department of Gynecology (including Breast Center) | CCM PD Dr. Mandy Mangler (acting) Specialty Network: Pediatrics and Youth Medicine Department of Pediatrics Endocrinology, Gastroenterology and Metabolic Medicine Prof. Dr. Philippe Stock (acting) Department of Pediatrics, Division of Cardiology Prof. Dr. Felix Berger Department of Pediatrics, Division of Pneumonology and Immunology Prof. Dr. Philippe Stock (acting) Department of Pediatrics, Division of Oncology and Hematology Prof. Dr. Angelika Eggert Department of Pediatrics, Division of Nephrology Prof. Dr. Uwe Querfeld Department of Pediatrics, Division of Neurology Prof. Dr. Christoph Hübner Department of Pediatric Surgery Prof. Dr. Karin Rothe Center for Social Pediatrics Dr. Theodor Michael Department of Child and Adolescent Psychiatry, Psychosomatic Medicine Prof. Dr. Ulrike Lehmkuhl and Psychotherapy Institute of Experimental Pediatric Endocrinology Prof. Dr. Heiko Krude Further Facilities Institute of Medical Genetics and Human Genetics Prof. Dr. Stefan Mundlos Institute of Medical Genetics Prof. Dr. Bernhard Herrmann

Last update: April 2014

23

Legal notice

Publisher Corporate Communications Division, Charité – Universitätsmedizin Berlin

Tel. +49 30 450 570 400 | presse@charite.de | www.charite.de

Responsible as per Press Law Uwe Dolderer, Head of Corporate Communications Division

Proofing Katja Barnikow, Verena Wolff, Manuela Zingl

Editing Dr. Katja Furthmann

Translations Jonathan MacKerron

Design Christine Voigts, Corinna Naujok

Zentrale Mediendienstleistungen, Charité – Universitätsmedizin Berlin

Photos Wiebke Peitz, Zentrale Mediendienstleistungen,

Charité – Universitätsmedizin Berlin

David Ausserhofer (page 3, Prof. Dr. Annette Grüters-Kieslich)

Marion Pfeil (page 4, left top; page 5, right top),

Ludes Architekten (page 4, right bottom),

Kerstin Müller (page 5, left middle), Franz Hafner (page 8, left top),

Tobias Hein, GRAFT Architekten (page 8, left middle),

Centre Virchow-Villermé (page 11, left top)